M-H Horellou - JoVE Visualize

Showing results (81-90 of 97) with videos related to

Pageof 10

Sort By:

Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994

Evaluation of desmopressin for dental extractions in patients with hemostatic disordersJ Saulnier, A Marey, M H Horellou, et al.

Thrombosis Research|November 5, 2002

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.

Thrombosis Research. Supplement|January 1, 1991

Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.

American Journal of Hematology|June 1, 1992

Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulinsA Delmer, M H Horellou, J M Bréchot, et al.

Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1986

[Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects]M Samama, E Verdy, J Conard, et al.

Blood|August 15, 1993

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiencyJ Conard, K A Bauer, A Gruber, et al.

Fundamental & Clinical Pharmacology|January 1, 1988

Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitroM Samama, G Nguyen, P Desnoyers, et al.

Annales De Medecine Interne|January 1, 1983

[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.

Journal of Wound Care|February 15, 2014

Skin necrosis due to fluindione treatment: a rare but serious complicationK Beqqal, M H Horellou, A Philippe, et al.

Transfusion Medicine (Oxford, England)|June 13, 2006

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.

Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:

Pageof 10

Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994

Evaluation of desmopressin for dental extractions in patients with hemostatic disordersJ Saulnier, A Marey, M H Horellou, et al.

Thrombosis Research|November 5, 2002

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.

Thrombosis Research. Supplement|January 1, 1991

Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgeryM M Samama, S Combe, M H Horellou, et al.

American Journal of Hematology|June 1, 1992

Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulinsA Delmer, M H Horellou, J M Bréchot, et al.

Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1986

[Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects]M Samama, E Verdy, J Conard, et al.

Blood|August 15, 1993

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiencyJ Conard, K A Bauer, A Gruber, et al.

Fundamental & Clinical Pharmacology|January 1, 1988

Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitroM Samama, G Nguyen, P Desnoyers, et al.

Annales De Medecine Interne|January 1, 1983

[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.

Journal of Wound Care|February 15, 2014

Skin necrosis due to fluindione treatment: a rare but serious complicationK Beqqal, M H Horellou, A Philippe, et al.

Transfusion Medicine (Oxford, England)|June 13, 2006

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.

Pageof 10